Tiny Health secures $8.5M funding for advancing at-home gut microbiome testing, totaling $13M. Spearheaded by Spero Ventures, it aims to address the escalating challenge of pediatric chronic conditions, affecting over 40% of US children. Founded in 2020 by a mother, Tiny Health offers comprehensive tests for adults and children, providing actionable recommendations to optimize gut health. They conduct IRB-approved clinical studies to assess effectiveness.
Tiny Health, a frontrunner in at-home gut microbiome testing, announces the successful closure of an $8.5M Series A funding round.
Spearheaded by Spero Ventures, this funding round elevates Tiny Health’s total investment to $13M, propelling its mission to redefine gut health innovation and tackle the mounting challenge of pediatric chronic conditions.
Addressing a National Challenge:
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The United States grapples with a surge in pediatric chronic conditions, affecting over 40% of children. These conditions encompass eczema, asthma, diabetes, obesity, and food allergies, exacerbating burdens on families and healthcare infrastructures.
A Personal Journey, A Collective Vision:
Established in 2020 by a mother driven to alleviate her child’s gut-related health issues, Tiny Health harnesses the expertise of microbiologists, pediatricians, and scientists. Their cutting-edge at-home tests offer:
– Thorough analyses of gut and vaginal microbiomes
– Practical recommendations to optimize gut health and rectify imbalances
– Identification of over 120,000 microbes through advanced shotgun metagenomics sequencing technology
Expanding their services to encompass adults, children aged 3-17, and vaginal health, Tiny Health addresses microbiome health across all life stages. Additionally, Tiny Health conducts clinical studies, approved by the Institutional Review Board (IRB), to assess the efficacy of their tests in enhancing health outcomes, particularly for mothers and infants.